GlassScriptPhysician profile
Fernando J Rivera
NPI 1073687992
$1,591.81
in general payments reported to CMS, 2019-2025
9 companies · $292 in 2025
The $292 reported for 2025 was more than what 75% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $125 · 2021: $153 · 2022: $154 · 2023: $145 · 2024: $372 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $447.25 | 2023-2025 | Qulipta |
| Astrazeneca Pharmaceuticals LP | $311.85 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $306.77 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Janssen Pharmaceuticals, INC | $226.98 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $124.52 | 2024-2025 | Watchman Flx |
| Pbg Puerto Rico LLC | $79.50 | 2019-2025 | |
| Amgen INC. | $64.87 | 2024 | Evenity |
| Sanofi Pasteur INC. | $16.89 | 2024 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.